Omega Healthcare Investors (OHI) Earnings Date & Reports

Omega reported total revenue of $322.955 million for the quarter ended March 31, 2026, well above the $266 million consensus estimate. Net income attributable to common stockholders climbed 42% year-over-year to $159 million, or $0.47 per diluted share, compared to analyst expectations around $0.54 GAAP EPS.

Core REIT metrics shone: Nareit-defined FFO totaled $249.5 million, or $0.79 per diluted share, aligning with consensus forecasts while surging 27% from Q1 2025's $0.62. AFFO came in at $259.7 million, or $0.82 per share, beating Zacks estimates by 2.5%. FAD rose 9.5% to $0.78 per share. Portfolio same-store occupancy ended at 82.6%, up from 82.2% a year earlier, with EBITDAR (Earnings Before Interest, Taxes, Depreciation, Amortization, and Rent) coverage at 1.58x.

The company deployed $251 million in investments, including real estate acquisitions yielding over 10%, loans, and equity stakes. It also advanced the $480 million sale of 18 CommuniCare facilities (12 closed in Q1). Liquidity stood at over $1.6 billion undrawn revolver capacity plus cash.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research workflow.

Market Reaction and Investor Sentiment

OHI shares closed up 1.68% at $47.46 on April 28 but fell 1.12% to $46.92 in extended trading, reflecting mixed sentiment despite operational beats. Investors appeared cautious over lingering tenant health issues, such as with Genesis, even as coverage improved and guidance rose. Pre-earnings positioning was neutral, with focus shifting to the April 29 conference call for deeper commentary on operator stability and deployment plans.

Forward Outlook and Key Factors to Monitor

Omega raised its full-year 2026 AFFO guidance to $3.19–$3.25 per diluted share (midpoint $3.22), up two cents from prior, incorporating Q1 strength, accretive investments, and the CommuniCare sale proceeds expected in Q2. This assumes $65 million in mortgage repayments, $224 million in loan paydowns (including Genesis), stable G&A of $14–15 million quarterly, and no further rate or FX shifts.

Investors should track execution on the $75 million April investments and broader pipeline, targeting high-yield opportunities in U.S. and U.K. SNFs. Portfolio management remains key, including four facilities sold in Q1 and 19 held for sale. Rising EBITDAR coverage signals tenant health recovery, but watch rent collection from major operators like Genesis and Maplewood.

Broader dynamics include interest rate sensitivity (debt maturities ahead), demographic-driven demand for senior housing, and competition for quality assets. Upcoming catalysts: Q2 results, dividend declarations, and equity issuances for growth funding.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations